Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
Mohadeseh Khoshandam, Hossein Soltaninejad, Marziyeh Mousazadeh, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 268-282
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
Razan Masarwy, Lior Stotsky‐Oterin, Aviad Elisha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115359-115359
Closed Access | Times Cited: 15
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 8
The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives
Cheng An, Zhen Li, Yao Chen, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Emerging technology has a brilliant future: the CRISPR-Cas system for senescence, inflammation, and cartilage repair in osteoarthritis
Shicheng Jia, Rongji Liang, Jiayou Chen, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy
Mingming Qin, Chunhao Deng, Liewei Wen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Convergence of CRISPR and artificial intelligence: A paradigm shift in biotechnology
Mahintaj Dara, Mehdi Dianatpour, Negar Azarpira, et al.
Human Gene (2024) Vol. 41, pp. 201297-201297
Closed Access | Times Cited: 4
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Rahul Mallick, Sanjay Basak, Parimal Chowdhury, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 104-104
Open Access
Exosome-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy
Bhavanisha Rithiga S, Rajib Dhar, Arikketh Devi
Gene (2025), pp. 149296-149296
Closed Access
CRISPR-Based Genetic Improvement of Aquaculture Species
Abdulkadir Bayır, Selma Saoula, Ammar Almansour, et al.
Fishes (2025) Vol. 10, Iss. 2, pp. 84-84
Open Access
Balancing benefits and burdens: a systematic review on ethical and social dimensions of gene and cell therapies for hereditary blood diseases
L. C. van Hooff, E.-M. Merz, Amanuel Gebremeskel, et al.
BMC Medical Ethics (2025) Vol. 26, Iss. 1
Open Access
Comprehensive strategies for constructing efficient CRISPR/Cas based cancer therapy: Target gene selection, sgRNA optimization, delivery methods and evaluation
Sathishbabu Paranthaman, Chinnappa A. Uthaiah, Shadab Md, et al.
Advances in Colloid and Interface Science (2025), pp. 103497-103497
Closed Access
CRISPR/Cas9 gene editing: a novel strategy for fighting drug resistance in respiratory disorders
Bashdar Mahmud Hussen, Zana B. Najmadden, Snur Rasool Abdullah, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
From resistance to remedy: the role of clustered regularly interspaced short palindromic repeats system in combating antimicrobial resistance—a review
Ali Raza, Pakiza Fatima, Bushra Yasmeen, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 4
Novel Therapeutic Approaches for the Management of Elevated Lipoprotein(a): From Traditional Agents to Future Treatment Options
György Paragh, Péter Zilahi, László Róbert Kolozsvári, et al.
Life (2024) Vol. 14, Iss. 3, pp. 374-374
Open Access | Times Cited: 3
A comprehensive review on utilizing CRISPR/Cas system for microbiome modification
Mohammad Abavisani, Navid Faraji, Saba Faraji, et al.
Biochemical Engineering Journal (2024) Vol. 211, pp. 109443-109443
Closed Access | Times Cited: 3
Improving the use of CRISPR/Cas9 gene editing machinery as a cancer therapeutic tool with the help of nanomedicine
Hina Fatima, Dimple Singh, H. Muhammad, et al.
3 Biotech (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 3
High-throughput CRISPR technology: a novel horizon for solid organ transplantation
Xiaohan Li, Zhang Chen, Weicong Ye, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 2
Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications
Allison Sharrar, Zuriah A. Meacham, Johanna Staples-Ager, et al.
The CRISPR Journal (2024) Vol. 7, Iss. 3, pp. 150-155
Closed Access | Times Cited: 2
Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases
Colin Walsh, Sha Jin
Cells (2024) Vol. 13, Iss. 12, pp. 1052-1052
Open Access | Times Cited: 2
Anticipatory gaps challenge the public governance of heritable human genome editing
Jon Rueda, Seppe Segers, Jeroen Hopster, et al.
Journal of Medical Ethics (2024), pp. jme-109801
Closed Access | Times Cited: 2
CRISPR/Cas and artificial intelligence to improve precision medicine: Future perspectives and potential limitations
Mohadeseh Khoshandam, Hossein Soltaninejad, Saman Hosseinkhani, et al.
Human Gene (2024) Vol. 42, pp. 201356-201356
Closed Access | Times Cited: 2
CRISPR, CAR-T, and NK: Current applications and future perspectives
Mohadeseh Khoshandam, Hossein Soltaninejad, Amir Ali Hamidieh, et al.
Genes & Diseases (2023) Vol. 11, Iss. 4, pp. 101121-101121
Open Access | Times Cited: 6
Application of CRISPR-Cas System to Mitigate Superbug Infections
Ali A. Rabaan, Mona A. Al Fares, Manar Almaghaslah, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2404-2404
Open Access | Times Cited: 5
CRISPR-Cas9 Genome Editing Technology for Zoonotic Disease Control in Indonesia: A Comprehensive Review
I Made Dwi Mertha Adnyana, Dwinka Syafira Eljatin, Ni Luh Gede Sudaryati, et al.
Journal of Medicine and Health Technology (2024) Vol. 1, Iss. 1, pp. 21-39
Open Access | Times Cited: 1
Targeted gene delivery through receptors with lipid nanoparticles
Venkanna Muripiti, Amarnath Velidandia, Yash Sharma, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105457-105457
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top